Showing 32,301 - 32,320 results of 113,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 2.13s Refine Results
  1. 32301
  2. 32302
  3. 32303
  4. 32304

    Tauroursodeoxycholic acid (TUDCA) attenuates ER stress and improves alveolarization in Tun-treated neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

    Published 2022
    “…<p>(<b>A</b>) The expression levels of ER stress sensors (P-PERK: 0.5±0.1-fold, p = 0.002814; P-IRE1α: 0.5±0.1-fold, p = 0.001463; cleaved ATF6: 0.6±0.1-fold, p<0.001, n = 9, 4 males and 5 females), GRP78 (0.6±0.1-fold, p<0.001, n = 9), CHOP (0.4±0.2-fold, p<0.001, n = 9), cleaved caspase-12 (0.5±0.1-fold, n = 13, 6 males and 7 females), and BAX/BCl<sub>2</sub> ratio (0.3±0.3-fold, p<0.001, n = 12, 6 for each sex) are all decreased while the glycosylated VEGFR2 is increased (3.0±0.3-fold, p<0.001, n = 9) by TUDCA in Tun treated neonatal lungs (n = 9–13) at P5. …”
  5. 32305
  6. 32306
  7. 32307
  8. 32308
  9. 32309
  10. 32310
  11. 32311

    Data_Sheet_1_Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials.docx by Jia Yao (323339)

    Published 2022
    “…</p>Results<p>In this study, thirty RCTs (n = 5,166) were included. In common cold, results showed that the flavonoids group decreased total cold intensity score (CIS), the sum of sum of symptom intensity differences (SSID) of CIS, and duration of inability to work vs. the control group. …”
  12. 32312

    TUDCA improves weight gain and alveolar formation in HOX rat pups. by Kirkwood A. Pritchard Jr. (13449794)

    Published 2022
    “…The weight gains start to decrease from P5 in HOX pups, while TUDCA improves the weight gains after P7. …”
  13. 32313

    DataSheet_1_Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis.docx by Xiao Wei (44054)

    Published 2023
    “…Rigosertib (ON 01910.Na) was associated with a decreased risk of AEs in digestive system (ES, 0.103; 95% CIs, 0.059-0.147), but BI 2536 and Volasertib (BI 6727) increased risk of AEs in blood system (ES, 0.399; 95% CIs, 0.294-0.504). …”
  14. 32314

    DataSheet_2_Effectiveness, safety and pharmacokinetics of Polo-like kinase 1 inhibitors in tumor therapy: A systematic review and meta-analysis.pdf by Xiao Wei (44054)

    Published 2023
    “…Rigosertib (ON 01910.Na) was associated with a decreased risk of AEs in digestive system (ES, 0.103; 95% CIs, 0.059-0.147), but BI 2536 and Volasertib (BI 6727) increased risk of AEs in blood system (ES, 0.399; 95% CIs, 0.294-0.504). …”
  15. 32315

    Antibody responses to varying doses of rhGAA in null mutation (n = 6) or P545L mutant mice (n = 5). by Sushrusha Nayak (371224)

    Published 2014
    “…<p><b>A</b>) Anti-rhGAA IgG1 in 1 mg/kg rhGAA injected GAA-/- 129SVE mice tested weekly <b>B</b>) Anti-rhGAA IgG1 in 5 mg/kg rhGAA injected GAA-/- 129SVE mice <b>C</b>) Anti-rhGAA IgG1 in 20 mg/kg rhGAA injected GAA-/- 129SVE mice <b>D</b>) Anti-rhGAA IgG1 response in 20 mg/kg rhGAA injected P545L mice <b>E</b>) Anti-rhGAA IgG2a in 1 mg/kg rhGAA injected GAA-/- 129SVE mice <b>F</b>) Anti-rhGAA IgG2a in 5 mg/kg rhGAA injected GAA-/- 129SVE mice <b>G</b>) Anti-rhGAA IgG2a in 20 mg/kg rhGAA injected GAA-/- 129SVE mice <b>H</b>) Anti-rhGAA IgG2a in 20 mg/kg rhGAA injected P545L mice. …”
  16. 32316

    DataSheet_1_Conservation and Evolution of Antigenic Determinants of SARS-CoV-2: An Insight for Immune Escape and Vaccine Design.pdf by Varun Jaiswal (730603)

    Published 2022
    “…Numerous highly conserved B- and T-cell epitopes were identified in 24 proteins of SARS-CoV-2. A decrease in the conservation of epitopes with time was observed in almost all proteins, which was more rapid in neutralizing epitopes. …”
  17. 32317
  18. 32318
  19. 32319
  20. 32320

    Supplementary Material for: Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Da... by Leite A.R. (9097394)

    Published 2023
    “…Lower FT3/FT4 ratio was associated with higher risk for the composite HF outcome (HR = 2.50, 95% CI: 1.04–5.88, per 1-unit decrease in FT3/FT4, <i>p</i> = 0.041). …”